We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bunzl Plc | LSE:BNZL | London | Ordinary Share | GB00B0744B38 | ORD 32 1/7P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
42.00 | 1.35% | 3,148.00 | 3,156.00 | 3,158.00 | 3,166.00 | 3,106.00 | 3,132.00 | 527,593 | 16:35:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Business Services, Nec | 11.8B | 526.2M | 1.5570 | 20.27 | 10.67B |
TIDMBNZL
RNS Number : 2386K
Bunzl PLC
20 December 2022
20 December 2022
BUNZL ANNOUNCEMENT REGARDING ACQUISITIONS AND DISPOSAL
Bunzl plc, the specialist international distribution and services Group, today announces that it has signed agreements to acquire four businesses and agreed to the sale of its UK healthcare division. Together, these transactions are expected to be profit neutral to the Group and will generate a small cash inflow. They reflect Bunzl's ongoing discipline around returns focused capital allocation and portfolio optimisation.
The Group has agreed to the sale of its UK healthcare division to Mediq. In 2021, the UK healthcare division generated GBP216 million of revenue.
The Group remains focused on expanding its specialist healthcare business and in November completed the acquisition of Toomac Ophthalmic & Solutions, a distributor of ophthalmology products in New Zealand. In the 12 months to March 2022 the business generated revenue of NZD 11 million (c.GBP6 million). In October, Bunzl also signed an agreement to acquire GRC, an exclusive distributor of innovative medical technology devices in Australia with revenue of AUD 4 million (c.GBP3 million) in the 12 months to June 2022. Both businesses specialise in surgical products and broaden the offering in Bunzl's healthcare business in the region, which has expanded significantly over the last two years.
In October, Bunzl also completed the acquisition of VM Footwear, a distributor of Personal Protection Equipment based in Czech Republic, specialising in own brand footwear throughout Central Eastern Europe and providing an entry into this category in the region. In the year to June 2022 the business generated CZK 366 million (c.GBP13 million) of revenue.
Furthermore, in November Bunzl completed the acquisition of PM Pack, a distributor of packaging products in Denmark, mainly focused on food processor customers. The acquisition strengthens the Group's foodservice offering in Denmark and in the year to September 2022 the business generated revenue of DKK 142 million (c.GBP16 million).
Frank van Zanten, Chief Executive Officer of Bunzl, said:
"Today's announcement reflects Bunzl's commitment to optimal capital allocation across the Group. The announced acquisitions are highly complementary, expand our product offering in each country, and all achieve double digit margins, with their profits offsetting the expected profit contribution from the announced disposal. I would like to offer a warm welcome to all the teams from the newly acquired businesses to the Bunzl family.
I want to thank our departing colleagues for all the contributions they made as part of Bunzl, particularly most recently for their incredible dedication to supporting customers during the pandemic. I wish the whole team the very best for the future."
Enquiries:
Bunzl plc Tulchan Frank van Zanten, Chief Executive Martin Robinson Officer Olivia Peters Richard Howes, Chief Financial Tel: +44 (0)20 7353 4200 Officer Sunita Entwisle, Head of Investor Relations Tel: +44 (0)20 7725 5000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ACQTLBLTMTABBTT
(END) Dow Jones Newswires
December 20, 2022 02:00 ET (07:00 GMT)
1 Year Bunzl Chart |
1 Month Bunzl Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions